Evidence map›Paper›PMID 31581466›Full record

ReviewAntibiotics (Basel, Switzerland)2019

Actinobacteria Derived from Algerian Ecosystems as a Prominent Source of Antimicrobial Molecules.

Ibtissem Djinni, Andrea Defant, Mouloud Kecha, Ines Mancini

Abstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Biocontrol of toxinogenicSaudi journal of biological sciences · 2022
    Article
  5. Article
  6. Article
  7. Review
  8. Natural Compounds as Antimicrobial Agents.Antibiotics (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ibtissem DjinniLaboratoire de Microbiologie Appliquée, Faculté des Sciences de la Nature et de la Vie, Université de Bejaia 06000, Algeria. ibtissem.djinni@yahoo.fr.
Andrea DefantBioorganic Chemistry Laboratory, Department of Physics, University of Trento, Trento 38123, Italy. defant.andrea@unitn.it.
Mouloud KechaLaboratoire de Microbiologie Appliquée, Faculté des Sciences de la Nature et de la Vie, Université de Bejaia 06000, Algeria. kmkmsetif@yahoo.fr.
Ines ManciniBioorganic Chemistry Laboratory, Department of Physics, University of Trento, Trento 38123, Italy. ines.mancini@unitn.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Actinobacteria, in particular "rare actinobacteria" isolated from extreme ecosystems, remain the most inexhaustible source of novel antimicrobials, offering a chance to discover new bioactive metabolites. This is the first overview on actinobacteria isolated in Algeria since 2002 to date with the aim to present their potential in producing bioactive secondary metabolites. Twenty-nine new species and one novel genus have been isolated, mainly from the Saharan soil and palm groves, where 37.93% of the most abundant genera belong to

Indexed as

actinobacteriaantibioticantifungalantimicrobialchemodiversityrare actinobacteriaSaharan ecosystem.secondary metabolites

Identifiers

PMID31581466
PMCPMC6963827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.